Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 79.00
-0.70 (-0.88%)
Aug 19, 2026, 9:49 AM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 5.18 billion as of August 18, 2026. Its market cap has increased by 122.36% in one year.
Market Cap
5.18B
Enterprise Value
4.75B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
79.00
ChartMarket Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 5.18B, an increase of 131.12%. That is a compound annual growth rate of 40.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 5.18B | 29.28% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acepodia | 6.91B |
| Savior Lifetec | 6.35B |
| TaiGen Biopharmaceuticals Holdings | 6.29B |
| Sinphar Pharmaceutical | 6.02B |
| TWi Biotechnology | 5.54B |
| AnnJi Pharmaceutical | 5.16B |
| Mycenax Biotech | 5.08B |
| Medigen Biotechnology | 4.70B |